Experimental Physiology
	

Celebrating 100 years
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Physiology in Press

First published online on May 12, 2005.
Experimental Physiology (2005)
DOI: 10.1113/expphysiol.2005.030080
© The Physiological Society 2005

A more recent version of this article appeared on July 1, 2005
This Article
Right arrow Full Text (Rapid PDF)
Right arrow All Versions of this Article:
90/4/449    most recent
expphysiol.2005.030080v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Touyz, R. M
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Touyz, R. M

Received April 1, 2005
Revised April 21, 2005
Accepted after revision May 10, 2005


Vascular physiology

Intracellular Mechanisms Involved in Vascular Remodeling of Resistance Arteries in Hypertension: Role of Angiotensin II

Rhian M Touyz 1*

1 University of Ottawa

* To whom correspondence should be addressed. E-mail: touyzr{at}ircm.qc.ca.


   Abstract
Resistance arteries undergo structural changes (vascular remodeling) in hypertension. These changes involve media thickening, reduced lumen diameter and consequent increased media:lumen ratio. Cellular processes underlying these events include altered vascular smooth muscle cell (VSMC) growth, migration, differentiation and increased extracellular matrix abundance. Another factor contributing to remodeling is inflammation, associated with macrophage infiltration, fibrosis and increased expression of redox-sensitive pro-inflammatory genes. Among the factors involved in arterial remodeling, Ang II appears to be one of the most important. Ang II, a multifunctional peptide with pleiotropic actions modulates vasomotor tone, cell growth, apoptosis/anoikis, cell migration and extracellular matrix deposition. It is proinflammatory and it stimulates production of growth factors and vasoactive agents. The multiple actions of Ang II are mediated via complex intracellular signaling pathways including stimulation of the PLC-IP3-DAG cascade, MAP kinases, tyrosine kinases and RhoA/Rho kinase. Furthermore, Ang II elicits many of its (patho)physiological effects by stimulating reactive oxygen species (•O2- and H2O2) generation through activation of vascular NAD(P)H oxidase. •O2- and H2O2 in turn influence downstream signaling molecules including transcription factors, tyrosine kinases/phosphatases, Ca2+ channels and MAP kinases. Interaction between these systems is complex and dysregulation at any level may contribute to vascular remodeling. Targeting such molecules/pathways could prevent or regress hypertensive vascular damage thereby ameliorating development of hypertension and preventing target organ damage. The present review discusses the role of Ang II in remodeling of resistance arteries, focusing on some signaling pathways involved in vascular growth and inflammation in hypertension.

Key Words: Angiotensin, Hypertension, Intracellular signalling







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Copyright © 2005 by the The Physiological Society.